Andhra Pradesh, India

Ramesh Devarapalli

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Cipla Limited. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ramesh Devarapalli. Retrieved from https://idiyas.com/inventor/ramesh-devarapalli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ramesh Devarapalli: Innovator in Pharmaceutical Sciences

Introduction

Ramesh Devarapalli is a notable inventor based in Andhra Pradesh, India. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of novel drug formulations. His work focuses on improving therapeutic treatments through innovative approaches.

Latest Patents

Ramesh holds a patent for "Polymorphs of Acalabrutinib," a Bruton's tyrosine kinase inhibitor. This invention discloses novel crystalline polymorphic forms of Acalabrutinib, along with methods of preparation, pharmaceutical compositions, and therapeutic treatment methods involving these polymorphic forms. This advancement has the potential to enhance the efficacy and safety of treatments for various conditions.

Career Highlights

Ramesh is currently employed at Cipla Limited, a leading global pharmaceutical company. His role involves research and development, where he applies his expertise to create innovative solutions in drug formulation and delivery. His dedication to advancing pharmaceutical science has positioned him as a key player in the industry.

Collaborations

Ramesh has collaborated with talented professionals such as Geena Malhotra and Venkata Srinivas Pullela. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Ramesh Devarapalli's contributions to pharmaceutical sciences through his patent on Acalabrutinib polymorphs exemplify his commitment to innovation. His work at Cipla Limited and collaborations with other professionals highlight the importance of teamwork in advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…